Chronic myeloid leukemia (CML) cells contain an abnormal gene, BCR-ABL, that isn't found in normal cells. This gene makes a protein, BCR-ABL, which causes CML cells to grow and reproduce out of ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy typically characterised by symmetrical involvement, and proximal as well as distal muscle weakness (typical ...

A patient who has headaches as many days as not — at least 15 days per month — is said to have chronic daily headache (CDH). Not a specific type of headache, CDH is rather a descriptive term applied ...

Orbital cellulitis and abscess formation are rare complications of sinusitis, however acute orbital inflammation is secondary to sinusitis in about 70% of cases. Delay in diagnosis must not occur to ...

In fact, controversies persist regarding mechanisms that determine the transition from the initial trigger to myocardial inflammation and from acute myocardial damage to chronic ventricular ...

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of this cell therapy in patients with recurrent or persistent SUI. In the following interview, Melissa ...

Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units ...

Acupuncture is effective for the treatment of chronic pain. The effects of acupuncture persist over time. The benefits of acupuncture cannot be explained solely by the placebo effect. In a series ...

In today’s health quiz, we dive into a symptom many people experience but often overlook—chronic fatigue. Feeling constantly drained despite a full night’s sleep? You’re not alone. Chronic fatigue ...

An immunopathological study was undertaken to test the hypothesis that idiopathic chronic cough is associated with lymphocytic airway inflammation. Methods: Bronchoscopy, bronchial biopsies, ...

The combination of avutometinib and defactinib is the first FDA-approved treatment for KRAS-mutated recurrent LGSOC. Approval was based on the phase 2 RAMP-201 trial, showing a 44% overall ...